Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 20/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13610241 | 0.89 | MAPK14 (0.64) | MAPK14 | |
| SCHEMBL4378757 | 0.87 | MAPK14 (0.64) | MAPK14 | |
| SCHEMBL4382256 | 0.83 | MAPK14 (0.59) | MAPK14 | |
| SCHEMBL4381956 | 0.82 | MAPK14 (0.66) | MAPK14 | |
| SCHEMBL4469946 | 0.82 | MAPK14 (0.41) | MAPK14 | |
| SCHEMBL4390400 | 0.81 | MAPK14 (0.64) | MAPK14 | |
| SCHEMBL4384658 | 0.81 | MAPK14 (0.61) | MAPK14 | |
| SCHEMBL4384661 | 0.81 | MAPK14 (0.61) | MAPK14 | |
| SCHEMBL4387211 | 0.80 | MAPK14 (0.63) | MAPK14 | |
| SCHEMBL4385117 | 0.80 | MAPK14 (0.63) | MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114748622-B | P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD | 弗尔康医疗公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-114732910-B | P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD | 弗尔康医疗公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-114748622-A | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | 弗尔康医疗公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-114732910-A | P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD | 弗尔康医疗公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-111601593-B | P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD | 弗尔康医疗公司 | 2022-04-15 | — | — | CN | disclosed |